Improve speech loudness and clarity
- Trial ID
- NCT06416553
- Official Title
- Home-based Non-invasive Brain Stimulation in Combination With Lee Silverman Voice Treatment on Hypokinetic Dysarthria in Parkinson's Disease
- Goal
- Improve speech loudness and clarity
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Masaryk University
- Study Type
- INTERVENTIONAL
- Enrollment
- 40 participants
- Conditions
- Parkinson Disease
- Interventions
- Home-based transcranial direct current stimulation- real tDCS, Home-based transcranial direct current stimulation- sham tDCS, Lee-Silverman voice treatment
Plain-Language Summary
The goal is to help with hypokinetic dysarthria, the soft, monotone or unclear speech many people with Parkinson's develop. The approach pairs home-based transcranial direct current stimulation, which uses a weak electrical current to gently boost activity in speech-related brain areas, with Lee Silverman Voice Treatment, an intensive program that trains louder, clearer speech, and participants get either real or sham tDCS while doing the voice therapy to see if stimulation adds benefit. They are enrolling adults 50 to 85 with clinically established Parkinson's who can cooperate, excluding people with major psychiatric disorders or hallucinations, dementia, epilepsy, or MRI-incompatible metal in the body.
Locations
- Central European Institute of Technology, Brno, Czechia
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Home-based transcranial direct current stimulation- real tDCS. The goal is to help with hypokinetic dysarthria, the soft, monotone or unclear speech many people with Parkinson's develop. The approach pairs home-based transcranial direct current stimulation, which uses a weak electrical current to gently boost activity in speech-related brain areas, with Lee Silverman Voice Treatment, an intensive program that trains louder, clearer speech, and participants get either real or sham tDCS while doing the voice therapy to see if stimulation adds benefit. They are enrolling adults 50 to 85 with clinically established Parkinson's who can cooperate, excluding people with major psychiatric disorders or hallucinations, dementia, epilepsy, or MRI-incompatible metal in the body.
- Who can participate?
- Participants must be between 50 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 10 months.